People with Crohn’s disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, according to a new study by Weill Cornell Medicine researchers.
A new study has unveiled a precise picture of how an ion channel found in most mammalian cells regulates its own function with a “ball-and-chain” channel-plugging mechanism, according to investigators at Weill Cornell Medicine.
A new AI-based system for analyzing images taken over time can accurately detect changes and predict outcomes, which may be useful across a wide range of medical and scientific applications.
Weill Cornell Medicine and Weill Bugando School of Medicine collaborate to strengthen medical education, health care and innovative global health research at both institutions.
Working toward more effective tuberculosis vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with “kill switches” that can be triggered to stop the bacteria after they activate an immune response.
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.
An interdisciplinary team of Cornell researchers is developing HelioSkin, an aesthetically appealing solar-collection fabric that is inspired by the biological mechanisms that enable plants to bend toward the sun.
A multinational, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
